Tual, Ailyn G.
HRN: 21-87-72 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/07/2022
CEFUROXIME 500MG (TAB)
09/07/2022
09/14/2022
PO
500 Mg
BID
Inevitable Abortion; Oligohydramnios
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes